{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:50:22Z","timestamp":1790347822159,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jneuroim.2017.01.023","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T19:00:30Z","timestamp":1486062030000},"page":"72-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats"],"prefix":"10.1016","volume":"305","author":[{"given":"Kota","family":"Moriguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.01.023_bb0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ana.20045","article-title":"Axonal protection using flecainide in experimental autoimmune encephalomyelitis","volume":"55","author":"Bechtold","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh328","article-title":"Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide","volume":"128","author":"Bechtold","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0015","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/brain\/awl216","article-title":"Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE","volume":"129","author":"Black","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1085\/jgp.99.2.217","article-title":"Mechanism of 4-aminopyridine action on voltage-gated potassium channels in lymphocytes","volume":"99","author":"Choquet","year":"1992","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0306-3623(82)90046-5","article-title":"The aminopyridines","volume":"13","author":"Glover","year":"1982","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2013.05.016","article-title":"4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis","volume":"248","author":"G\u00f6bel","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomized, double-blind, controlled trial","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0040","series-title":"Peripheral Neuropathy","first-page":"418","article-title":"Immune reactions in the peripheral nervous system","author":"Hartung","year":"1993"},{"issue":"6","key":"10.1016\/j.jneuroim.2017.01.023_bb0045","first-page":"943","article-title":"Minimally invasive motor nerve conduction study of the rat sciatic and tail nerves","volume":"19","author":"Huseyinoglu","year":"2013","journal-title":"Kafkas Univ. Vet. Derg."},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0050","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/0924-980X(95)93268-X","volume":"97","author":"Kawasaki","year":"1995","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.01.023_bb0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jns.12169","article-title":"Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system","volume":"21","author":"Leussink","year":"2016","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2017.01.023_bb0060","first-page":"3","article-title":"Improvement of motor, sensory, and functional status of post-Guillain-Barre syndrome with the use of 4-aminopyridine","volume":"2","author":"Meythaler","year":"2014","journal-title":"Int. J. Phys. Med. Rehabil."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816304453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816304453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:06Z","timestamp":1759048146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816304453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":12,"alternative-id":["S0165572816304453"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.023","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}